Ketamine/Placebo Family History Positive Study

Conditions

Alcoholism

What is the purpose of this trial?

The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.



Participation Guidelines

Age:
21 Years - 30 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
VA Connecticut Healthcare System
Yale University
Dates:
March 2001
Last Updated:
February 14, 2013
Study HIC#:
0103012310

Clinicaltrials.gov ID: NCT00588952